Cynosure, Inc. (CYNO.W)
10.17USD
28 Jan 2010
$0.47 (+4.86%)
$10.17
--
$10.23
$9.76
36,967
34,346
$12.62
$4.50
CYNO.W
About
Overall
| Beta: | 2.24 |
| Market Cap (Mil.): | $129.40 |
| Shares Outstanding (Mil.): | 12.75 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| CYNO.W | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 6.39 | 3.76 |
| EPS (TTM): | -325.14 | -- | -- |
| ROI: | -17.07 | 1.18 | 2.30 |
| ROE: | -17.23 | 1.76 | 2.82 |
UPDATE 1-Cynosure settles patent lawsuit against CoolTouch
* CoolTouch to pay 9 pct royalty on sales of laser system
CORRECTED - CORRECTED-BRIEF-Cynosure signs agreement with Unilever
July 1 (Reuters) - Cynosure Inc : * Signs agreement with Unilever to develop light-based devices for home use * Says financial terms of the agreement were not disclosed
RPT-STOCKS TO WATCH - Giovedì 16 aprile, ore 8,35
***************** CHIUSURE MERCOLEDÌ 15 APRILE ******************
UPDATE 2-Cynosure shares fall on Q1 loss forecast
* Shares down more than 14 pct (Adds analyst's comments, details, updates share movement)
US RESEARCH SUMMARY-Non-S&P 500 Jan 26 1731 GMT
Following is a summary of research actions on non-S&P 500 companies reported by Reuters on Monday. Stock entries are in alphabetical order. For a summary of research on S&P 500 companies, double click on [RCH/US]. For a summary of research on Canadian companies, double click on [RCH/CA]. --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Agnico-Eagle Mines HSBC Cuts to underweight from neutr
UPDATE 2-Cynosure sees Q4 loss; shares down
BANGALORE, Jan 15 (Reuters) - Cynosure Inc , a maker of aesthetic laser devices, forecast a quarterly loss after several customers delayed purchases, sending shares down over 15 percent.
UPDATE 1-Cynosure Q3 profit misses estimates; shares sink
Oct 28 (Reuters) - Cynosure Inc posted lower
UPDATE 1-Cynosure Q2 profit in line with Wall Street
July 29 (Reuters) - Aesthetic laser device maker Cynosure Inc posted a second-quarter profit that was in line with market estimates, as weak market trends for anti-aging and hair removal products were offset by demand for its laser-assisted fat reduction system Smartlipo.
Cosmetic laser firms must tread new path to fight slump
BANGALORE (Reuters) - Aesthetic laser device makers will face tough times ahead unless they make deeper forays into new areas like liposuction and body contouring to overcome a saturated market for their flagship hair removal and wrinkle treatment products.
US RESEARCH NEWS-Friedman starts Merit Medical Systems
Following are the research actions reported by Reuters on Thursday as of 0833 ET. For a snapshot of research actions, please double click on [SNAP/RCH] --------------------------------------------------------------- ------------ STOCK RESEARCH BY ACTION Merit Medical Systems Friedman Starts with outperform rating; price
Competitors
| Price | Change | |
|---|---|---|
| Syneron Medical Ltd. (ELOS.OQ) | $9.10 | -0.16 |
| Palomar Medical Technologies, Inc. (PMTI.OQ) | $9.08 | +0.06 |
| Cutera, Inc. (CUTR.OQ) | $9.01 | +0.01 |
| Solta Medical Inc. (SLTM.OQ) | $1.89 | -0.02 |
| Candela Corporation (CLZR.OQ) | -- | -- |
| El.En. SpA (ELEN.MI) | €12.25 | +0.42 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
